Press Release
AstraZeneca today announced that the US Food and Drug Administration (FDA) approved the orphan drug vandetanib for the treatment of medullary thyroid cancer that cannot be removed by surgery or that has spread to other parts of the body.
Read more on PharmiWeb
RCC Amazing Touch - 71% OFF on a Whitening Facial
Today's Deal: Only P130 for a Whitening Facial Treatment at RCC Amazing Touch (valued at P450) Save P320! DetailsReservation required, please call the number below
Tidak ada komentar:
Posting Komentar